GOODMAN NOAH (Chief Business Officer) sold 6.7% of their position (3.39K shares) of KYMERA THERAPEUTICS, INC. on the open market
Open‑market sale worth $387.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/2/2026ACC: 0001193125-26-295089
Officer· Chief Business Officer
Since Mar 2026
-3.39K
Net shares
Net seller
$387.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.39K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.39K
Price / share
$114.29
Trade value
$387.33K
% of position
6.7%
7/1/2026
50.57K→47.18K
Total
Net shares
−3.39K
Net value
-$387.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2026 | S · Sale | −3.39K | $114.29 | $387.33K | 6.7% | 50.57K | 47.18K |
| Total | −3.39K | -$387.33K | ||||||
Derivative Transactions0
No derivative transactions reported